Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 6098

Like many other companies, Adobe is leveraging deep learning to improve its applications and solidify its position in the video and image editing market. In turn, the use of AI is shaping Adobe’s product strategy.

AI-powered image and video editing

Sensei, Adobe’s AI platform, is now integrated into all the products of its Creative Cloud suite. Among the features revealed in this year’s conference is an auto-masking tool in Photoshop, which enables you to select an object simply by hovering your mouse over it. A similar feature automatically creates mask layers for all the objects it detects in a scene.

Read more | >

Facebook founder Mark Zuckerberg accused other tech companies of “stifling innovation” with high fees and little choice for consumers during a live stream on Thursday, all while his company faces an antitrust lawsuit from the federal government and heightened pressure from Congress over recently-leaked internal documents

Zuckerberg made the comments at the Facebook Connect event Thursday, where he announced the company has changed its name to Meta.

He also laid out the company’s plans to build a metaverse — a virtual reality experience where people can meet online. His comments seemed to allude to mobile operating systems like those created by Apple and Google, though he did not mention any company by name or specify the types of platforms he was talking about.

Read more | >

Will drone deliveries be a practical part of our future? We visit the test facilities of Wing to check out how their engineers and aircraft designers have developed a drone and drone fleet control system that is actually in operation today in parts of the world. Here’s how their VTOL drone works and what it’s like to both load and receive a package carried by an autonomous aircraft!

Shot by Joey Fameli and edited by Norman Chan.
Additional footage courtesy of Wing.
Music by Jinglepunks.

Join this channel to support Tested and get access to perks:
https://www.youtube.com/channel/UCiDJtJKMICpb9B1qf7qjEOA/join.

Tested Ts, stickers, mugs and more: https://tested-store.com.

Continue reading “How Google’s Wing Drone Delivery Aircraft Works” | >

For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought. Their results could have important implications for the development of potential treatments.

The international team, led by the University of Cambridge, found that instead of starting from a single point in the brain and initiating a chain reaction that leads to the death of brain cells, Alzheimer’s disease reaches different regions of the brain early. How quickly the disease kills cells in these regions, through the production of toxic protein clusters, limits how quickly the disease progresses overall.

The researchers used post-mortem brain samples from Alzheimer’s patients, as well as PET scans from living patients, who ranged from those with mild cognitive impairment to those with late-stage Alzheimer’s disease, to track the aggregation of tau, one of two key proteins implicated in the condition.

Read more | >

Researchers at MIT and Harvard University have designed a way to selectively turn on gene expression in target cells, including human cells. Their technology can detect specific mRNA sequences (represented in the center of the illustration), which triggers production of a specific protein (bottom right). Credit: Jose-Luis Olivares, MIT, with figures from iStockphoto.

“This brings new control circuitry to the emerging field of RNA therapeutics, opening up the next generation of RNA therapeutics that could be designed to only turn on in a cell-specific or tissue-specific way,” says James Collins, the Termeer Professor of Medical Engineering and Science in MIT’s Institute for Medical Engineering and Science (IMES) and Department of Biological Engineering and the senior author of the study.

This highly targeted approach, which is based on a genetic element used by viruses to control gene translation in host cells, could help to avoid some of the side effects of therapies that affect the entire body, the researchers say.

Read more | >